fbpx Back to Top
FundFinder App Logo link
Home PAN Foundation click for home.
  • Search
PAN Foundation click for home. PAN Foundation click for home.

Macular Diseases

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Program Fully Allocated

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s Macular Diseases fund is currently closed. As of December 19, 2018, Good Days is accepting applications. 

 

Assistance Amount

$2,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for macular diseases.
  2. The patient must have Medicare health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Avastin (bevacizumab)
  • Eylea (aflibercept)
  • Iluvien (fluocinolone acetonide)
  • Jetrea (ocriplasmin/pf)
  • Lucentis (ranibizumab)
  • Macugen (pegaptanib sodium)
  • Ozurdex (dexamethasone)
  • Retisert (fluocinolone acetonide)
  • Triesence (triamcinolone acetonide/pf)
  • Visudyne (verteporfin)

Diagnosis Codes:

ICD-10: E08.311, E08.321, E08.3211-E08.3213, E08.3219, E08.331-E08.3313, E08.3319, E08.341-E08.3413, E08.3419, E08.351-E08.3513, E08.3519, E08.3521-E08.3523, E08.3529, E09.311, E09.321-E09.3213, E09.3219, E09.331, E09.3313, E09.3319, E09.341-E09.3413, E09.3419, E09.351-E09.3513, E09.3519, E09.3521-E09.3523, E09.3529, E09.37X1-E09.37X3, E09.37X9, E10.311, E10.321-E10.3213, E10.3219, E10.331-E10.3313, E10.3319, E10.341-E10.3413, E10.3419, E10.351-E10.3513, E10.3519, E10.3521-E10.3523, E10.3529, E10.37X1-E10.37X3, E10.37X9, E11.311, E11.321-E11.3213, E11.3219, E11.331-E11.3313, E11.3319, E11.341-E11.3413, E11.3419, E11.351-E11.3513, E11.3519, E11.3521-E11.3523, E11.3529, E11.37X1-E11.37X3, E11.37X9, E13.3211-E13.3213, E13.3219, E13.3311-E13.3313, E13.3319, E13.3411-E13.3413, E13.3419, E13.3511-E13.3513, E13.3519, E13.3521-E13.3523, E13.3529, E13.37X1-E13.37X3, E13.37X9, H35.30-H35.3114, H35.3120-H35.3124, H35.3130-H35.3134, H35.3190-H35.3194, H35.32-H35.3213, H35.3220-H35.3223, H35.3230-H35.3233, H35.3290-H35.3293, H35.33, H35.341-H35.343, H35.349, H35.351-H35.353, H35.359, H35.361-H35.363, H35.369, H35.371-H35.373, H35.379, H43.821-H43.823, H43.829, H43.829

 

Related Organizations: